Petter Brodin
Director/Board Member at KANCERA AB
Network origin in Petter Brodin first degree
Entity | Entity type | Industry | |
---|---|---|---|
Karolinska Institutet
95
| College/University | Other Consumer Services | 95 |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital.
20
| Non-Profit Organization | Hospital/Nursing Management | 20 |
13
| Public Company | Pharmaceuticals: Major | 13 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Petter Brodin via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
SVENSKA CELLULOSA AKTIEBOLAGET SCA | Pulp & Paper | Human Resources Officer Director/Board Member | |
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
Din Bostad Sverige AB
Din Bostad Sverige AB Real Estate DevelopmentFinance Din Bostad Sverige AB operates a residential property business. The company is headquartered in Huddinge, Sweden. | Real Estate Development | Director/Board Member Chief Tech/Sci/R&D Officer | |
Royal Swedish Academy of Sciences
Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Sciences provides research and development services on sciences. The non-profit company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
OREXO AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
University of Uppsala | College/University | Doctorate Degree Graduate Degree Masters Business Admin Doctorate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
University of Stockholm | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree | |
ONCOPEPTIDES AB | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
Royal Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
University of Lund | College/University | Doctorate Degree Masters Business Admin Corporate Officer/Principal Doctorate Degree | |
Nanyang Technological University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Fastilium Property Group AB
Fastilium Property Group AB Real Estate DevelopmentFinance Fastilium Property Group AB engages in the development and management of residential and commercial properties. The company was founded on June 7, 2006, and is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member Chief Executive Officer | |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
University of Gothenburg | College/University | Doctorate Degree Corporate Officer/Principal | |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | President President | |
Astra Arcus AB | Corporate Officer/Principal Corporate Officer/Principal | ||
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder | |
BIOARCTIC AB | Pharmaceuticals: Major | Founder Director/Board Member | |
Karolinska Institutet Innovations AB
Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Chairman Director/Board Member Director/Board Member Director/Board Member | |
iNovacia AB
iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Miscellaneous Commercial Services | Chief Executive Officer Founder | |
NovaSAID AB
NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member Founder | |
NEOS AB | Medical Specialties | Director/Board Member Founder Founder | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Chief Operating Officer Director/Board Member | |
DIAMYD MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
MENDUS AB | Biotechnology | Director/Board Member Director/Board Member | |
Blasieholmen Investment Group AB | Director/Board Member Director/Board Member | ||
SALTX TECHNOLOGY HOLDING AB | Electronic Production Equipment | Chairman Chief Executive Officer | |
NICOCCINO HOLDING AB | Tobacco | Director/Board Member Director of Finance/CFO | |
KARESSA PHARMA HOLDING AB (PUBL) | Pharmaceuticals: Major | Chairman Director of Finance/CFO Director/Board Member Director/Board Member | |
KLARIA PHARMA HOLDING AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member Chief Executive Officer | |
Klaria AB
Klaria AB Pharmaceuticals: MajorHealth Technology Part of Klaria Pharma Holding AB, Klaria AB develops pharmaceuticals. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
INITIATOR PHARMA A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
Stockholm Brain Institute | Director/Board Member Director/Board Member | ||
ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Founder | |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
BACTIGUARD HOLDING AB | Medical Specialties | Director/Board Member Director/Board Member |
Statistics
International
Sweden | 44 |
United States | 3 |
Denmark | 3 |
United Kingdom | 2 |
Singapore | 2 |
Sectoral
Health Technology | 25 |
Commercial Services | 8 |
Consumer Services | 8 |
Finance | 6 |
Process Industries | 2 |
Operational
Director/Board Member | 450 |
Corporate Officer/Principal | 226 |
Chairman | 111 |
Independent Dir/Board Member | 80 |
Founder | 64 |
Most connected contacts
- Stock Market
- Insiders
- Petter Brodin
- Company connections